DC Investments Management’s Novartis NVS Stock Holding History

DC Investments Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-3,344	Closed	-$316K	–	66
2020 Q4	$316K	Buy	+3,344	New	+$292K	0.79%	33
2020 Q3	–	Sell	-11,599	Closed	-$1.01M	–	222
2020 Q2	$1.01M	Buy	11,599 +1,780	+18%	+$154K	0.37%	30
2020 Q1	$810K	Sell	9,819 -1,513	-13%	-$135K	0.66%	21
2019 Q4	$1.07M	Buy	11,332 +456	+4%	+$40.9K	0.82%	9
2019 Q3	$945K	Hold	10,876	–	–	0.55%	14
2019 Q2	$993K	Buy	10,876 +544	+5%	+$46K	0.56%	10
2019 Q1	$890K	Hold	10,332	–	–	0.56%	22
2018 Q4	$794K	Buy	+10,332	New	+$804K	0.65%	19
2018 Q2	–	Sell	-10,740	Closed	-$778K	–	370
2018 Q1	$778K	Buy	10,740 +1,263	+13%	+$96.1K	0.52%	63
2017 Q4	$713K	Buy	+9,477	New	+$715K	0.29%	91

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

DC Investments Management's NVS Position: Q1 2021 in Review

DC Investments Management sold out of Novartis (NVS) in Q1 2021, closing a stake of 3,344 shares — an estimated $316K sold.

DC Investments Management first reported a position in NVS in Q4 2017 and held it in 10 quarters. The position peaked at $1.07M in Q4 2019. 1,135 funds tracked by Wall St. Rank hold NVS as of Q1 2021.

DC Investments Management reported no remaining Novartis position as of Q1 2021 after selling out during the quarter.
DC Investments Management sold 3,344 Novartis shares in Q1 2021, an estimated $316K.
DC Investments Management first reported a position in Novartis in Q4 2017 and held it in 10 quarters.
DC Investments Management's Novartis position peaked at $1.07M in Q4 2019.
1,135 funds tracked by Wall St. Rank held Novartis as of Q1 2021.

Based on DC Investments Management's 13F filing for Q1 2021, filed 14 May 2021.